Additionally, leptin favors breast cancer progression by inducing cellular proliferation by binding to its receptor followed by downstream signaling through NFκB, STAT3, ERK1/ERK2, and phosphoinositide-3-kinase (PI3K) pathways (56, 57). This evidence concerns the gene STAT3 and breast carcinoma.